Company · CIK 0001556263 · SIC 2834 — Pharmaceutical Preparations
Syros Pharmaceuticals, Inc. · SYRS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2019 SForm 4 → | Mar 11, 5:58 pm EDT | ARCH Venture Fund VII, L.P. +510% Owner | 164,583 | $6.80 | $1,118,649 | 4,472,554 | −3.55% | plan? |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:19 pm EST | Jeremy P. SpringhornChief Business Officer | 87,000 | — | — | 102,000 | — | plan? |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:19 pm EST | Nancy A SimonianPresident & CEO, Director | 188,000 | — | — | 669,288 | — | plan? |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:18 pm EST | David RothChief Medical Officer | 87,000 | — | — | 87,000 | — | plan? |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:18 pm EST | Gerald E QuirkChief Legal & Admin. Officer | 87,000 | — | — | 87,000 | — | plan? |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:17 pm EST | Eric R OlsonChief Scientific Officer | 87,000 | — | — | 87,000 | — | plan? |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:17 pm EST | Joseph J Ferra Jr.Chief Financial Officer | 87,000 | — | — | 87,000 | — | plan? |
| Nov 29, 2018 MForm 4 → | Dec 3, 4:06 pm EST | Nancy A SimonianPresident & CEO, Director | 110,588 | $1.23 | $136,224 | 481,288 | — | plan? |
| Jan 31, 2018 PForm 4 → | Feb 2, 3:53 pm EST | Srinivas AkkarajuDirector | 209,424 | $9.55 | $1,999,999 | 1,059,938 | +24.6% | plan? |
| Dec 15, 2017 PForm 4 → | Dec 15, 4:02 pm EST | Jeremy P. SpringhornChief Business Officer | 15,000 | $9.08 | $136,260 | 15,000 | — | plan? |
| Dec 12, 2017 PForm 4 → | Dec 14, 8:22 pm EST | Srinivas AkkarajuDirector | 109,774 | $9.03 | $991,558 | 830,494 | +15.2% | plan? |
| Oct 23, 2017 SForm 4 → | Oct 23, 4:44 pm EDT | Colleen Elizabeth DeSimonePrincipal Accounting Officer | 550 | $16.06 | $8,833 | 0 | −100% | plan? |
| Oct 23, 2017 MForm 4 → | Oct 23, 4:44 pm EDT | Colleen Elizabeth DeSimonePrincipal Accounting Officer | 550 | $3.04 | $1,672 | 550 | — | plan? |
| Sep 8, 2017 GForm 5 → | Feb 13, 2018, 6:43 pm EST | Noubar Afeyan10% Owner | 24,527 | — | — | 0 | — | plan? |
| Aug 17, 2017 JForm 4 → | Aug 21, 4:19 pm EDT | Flagship Ventures Fund IV, L.P. +510% Owner | 1,656,512 | — | — | 0 | — | plan? |
| Aug 14, 2017 SForm 4 → | Aug 16, 4:08 pm EDT | Richard A YoungDirector | 3,282 | $22.00 | $72,204 | 420,101 | −0.78% | plan? |
| Aug 7, 2017 SForm 4 → | Aug 8, 5:20 pm EDT | Eric R OlsonChief Scientific Officer | 2,500 | $23.59 | $58,969 | 0 | −100% | plan? |
| Aug 7, 2017 MForm 4 → | Aug 8, 5:20 pm EDT | Eric R OlsonChief Scientific Officer | 2,500 | $1.01 | $2,525 | 2,500 | — | plan? |
| Jul 25, 2017 SForm 4 → | Jul 27, 4:09 pm EDT | Eric R OlsonChief Scientific Officer | 12,500 | $21.85 | $273,125 | 0 | −100% | plan? |
| Jul 25, 2017 MForm 4 → | Jul 27, 4:09 pm EDT | Eric R OlsonChief Scientific Officer | 12,500 | $1.01 | $12,625 | 12,500 | — | plan? |
| Jul 25, 2017 SForm 4 → | Jul 27, 4:09 pm EDT | Richard A YoungDirector | 3,282 | $22.09 | $72,496 | 423,383 | −0.77% | plan? |
| Feb 9, 2017 JForm 5 → | Feb 13, 5:15 pm EST | Richard A YoungDirector | 106,667 | — | — | 426,665 | — | plan? |
| Jul 6, 2016 PForm 4 → | Jul 7, 5:41 pm EDT | Amir NashatDirector, 10% Owner | 400,000 | $12.50 | $5,000,000 | 48,320 | — | plan? |
| Jul 6, 2016 CForm 4 → | Jul 7, 5:41 pm EDT | Amir NashatDirector, 10% Owner | 1,186,653 | — | — | 22,167 | — | plan? |
| Jul 6, 2016 PForm 4 → | Jul 7, 5:41 pm EDT | Polaris Management Co. VII, L.L.C. +210% Owner | 400,000 | $12.50 | $5,000,000 | 48,320 | — | plan? |
| Jul 6, 2016 CForm 4 → | Jul 7, 5:41 pm EDT | Polaris Management Co. VII, L.L.C. +210% Owner | 1,186,653 | — | — | 22,167 | — | plan? |
| Jul 6, 2016 CForm 4 → | Jul 7, 8:15 am EDT | WuXi PharmTech Healthcare Fund I L.P.10% Owner | 931,857 | — | — | 931,857 | — | plan? |
| Jul 6, 2016 PForm 4 → | Jul 7, 6:04 am EDT | Flagship Ventures Fund IV, L.P. +510% Owner | 400,000 | $12.50 | $5,000,000 | 918,664 | +77.1% | plan? |
| Jul 6, 2016 CForm 4 → | Jul 7, 6:04 am EDT | Flagship Ventures Fund IV, L.P. +510% Owner | 4,193,324 | — | — | 838,664 | — | plan? |
| Jul 6, 2016 PForm 4 → | Jul 7, 6:03 am EDT | Redmile Group, LLC +110% Owner | 432,746 | $12.50 | $5,409,325 | 49,793 | — | plan? |
| Jul 6, 2016 CForm 4 → | Jul 7, 6:03 am EDT | Redmile Group, LLC +110% Owner | 466,182 | — | — | 40,420 | — | plan? |
| Jul 6, 2016 PForm 4 → | Jul 7, 6:02 am EDT | Arch Venture Fund VII LP +410% Owner | 400,000 | $12.50 | $5,000,000 | 4,637,137 | +9.44% | plan? |
| Jul 6, 2016 CForm 4 → | Jul 7, 6:02 am EDT | Arch Venture Fund VII LP +410% Owner | 4,023,804 | — | — | 4,237,137 | — | plan? |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:25 pm EDT | WuXi Healthcare Ventures II, L.P.10% Owner | 423,805 | — | — | 423,805 | — | plan? |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:24 pm EDT | Stephane BancelDirector | 26,666 | — | — | 47,980 | — | plan? |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:23 pm EDT | Philip A SharpDirector | 266,666 | — | — | 40,000 | — | plan? |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:23 pm EDT | Nancy A SimonianPresident and CEO, Director | 66,666 | — | — | 370,702 | — | plan? |
| Jul 6, 2016 PForm 4 → | Jul 6, 9:22 pm EDT | Robert NelsenDirector, 10% Owner | 400,000 | $12.50 | $5,000,000 | 4,637,137 | +9.44% | plan? |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:22 pm EDT | Robert NelsenDirector, 10% Owner | 4,023,804 | — | — | 4,237,137 | — | plan? |
| Jul 6, 2016 PForm 4 → | Jul 6, 5:10 pm EDT | AISLING CAPITAL III LP +510% Owner | 400,000 | $12.50 | $5,000,000 | 908,565 | +78.7% | plan? |
| Jul 6, 2016 CForm 4 → | Jul 6, 5:10 pm EDT | AISLING CAPITAL III LP +510% Owner | 508,565 | — | — | 508,565 | — | plan? |
| Jul 6, 2016 PForm 4 → | Jul 6, 11:54 am EDT | James E Flynn +510% Owner | 400,000 | $12.50 | $5,000,000 | 628,566 | +175% | plan? |
| Jul 6, 2016 CForm 4 → | Jul 6, 11:54 am EDT | James E Flynn +510% Owner | 1,695,220 | — | — | 508,566 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2019 AForm 4 → | Feb 14, 5:19 pm EST | Jeremy P. SpringhornChief Business Officer | 75,000 | — | — | 75,000 | — | |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:19 pm EST | Nancy A SimonianPresident & CEO, Director | 285,000 | — | — | 285,000 | — | |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:18 pm EST | David RothChief Medical Officer | 75,000 | — | — | 75,000 | — | |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:18 pm EST | Gerald E QuirkChief Legal & Admin. Officer | 75,000 | — | — | 75,000 | — | |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:17 pm EST | Eric R OlsonChief Scientific Officer | 75,000 | — | — | 75,000 | — | |
| Feb 12, 2019 AForm 4 → | Feb 14, 5:17 pm EST | Joseph J Ferra Jr.Chief Financial Officer | 75,000 | — | — | 75,000 | — | |
| Nov 29, 2018 MForm 4 → | Dec 3, 4:06 pm EST | Nancy A SimonianPresident & CEO, Director | 110,588 | — | — | 785,523 | — | |
| Jun 14, 2018 AForm 4 → | Jun 15, 4:30 pm EDT | Richard A YoungDirector | 11,000 | — | — | 11,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 15, 4:30 pm EDT | Peter WirthDirector | 11,000 | — | — | 11,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 15, 4:29 pm EDT | Philip A SharpDirector | 11,000 | — | — | 11,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 15, 4:29 pm EDT | Vicki L SatoDirector | 11,000 | — | — | 11,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 15, 4:29 pm EDT | Amir NashatDirector | 11,000 | — | — | 11,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 15, 4:28 pm EDT | Marsha FanucciDirector | 11,000 | — | — | 11,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 15, 4:28 pm EDT | Michael W BonneyDirector | 13,000 | — | — | 13,000 | — | |
| Jun 14, 2018 AForm 4 → | Jun 15, 4:24 pm EDT | Srinivas AkkarajuDirector | 11,000 | — | — | 11,000 | — | |
| Mar 12, 2018 AForm 4 → | Mar 12, 5:10 pm EDT | Joseph J Ferra Jr.Chief Financial Officer | 200,000 | — | — | 50,000 | — | |
| Feb 16, 2018 AForm 4 → | Feb 21, 4:09 pm EST | Gerald E QuirkChief Legal Officer | 86,666 | — | — | 11,666 | — | |
| Feb 16, 2018 AForm 4 → | Feb 21, 4:08 pm EST | David RothChief Medical Officer | 75,000 | — | — | 75,000 | — | |
| Feb 16, 2018 AForm 4 → | Feb 21, 4:08 pm EST | Eric R OlsonChief Scientific Officer | 75,000 | — | — | 75,000 | — | |
| Feb 16, 2018 AForm 4 → | Feb 21, 4:08 pm EST | Nancy A SimonianPresident & CEO, Director | 285,000 | — | — | 285,000 | — | |
| Nov 13, 2017 AForm 4 → | Nov 14, 5:15 pm EST | Jeremy P. SpringhornChief Business Officer | 200,000 | — | — | 50,000 | — | |
| Oct 23, 2017 MForm 4 → | Oct 23, 4:44 pm EDT | Colleen Elizabeth DeSimonePrincipal Accounting Officer | 550 | — | — | 13,016 | — | |
| Aug 7, 2017 MForm 4 → | Aug 8, 5:20 pm EDT | Eric R OlsonChief Scientific Officer | 2,500 | — | — | 110,075 | — | |
| Jul 25, 2017 MForm 4 → | Jul 27, 4:09 pm EDT | Eric R OlsonChief Scientific Officer | 12,500 | — | — | 25,025 | — | |
| Jun 8, 2017 AForm 4/A → | Sep 22, 5:20 pm EDT | Robert NelsenDirector, 10% Owner | 11,000 | — | — | 11,000 | — | |
| Jun 8, 2017 AForm 4/A → | Sep 22, 5:20 pm EDT | Richard A YoungDirector | 11,000 | — | — | 11,000 | — | |
| Jun 8, 2017 AForm 4/A → | Sep 22, 5:20 pm EDT | Philip A SharpDirector | 11,000 | — | — | 11,000 | — | |
| Jun 8, 2017 AForm 4/A → | Sep 22, 5:20 pm EDT | Vicki L SatoDirector | 11,000 | — | — | 11,000 | — | |
| Jun 8, 2017 AForm 4/A → | Sep 22, 5:19 pm EDT | Sanj K PatelDirector | 11,000 | — | — | 11,000 | — | |
| Jun 8, 2017 AForm 4/A → | Sep 22, 5:19 pm EDT | Amir NashatDirector | 11,000 | — | — | 11,000 | — | |
| Jun 8, 2017 AForm 4/A → | Sep 22, 5:19 pm EDT | Marsha FanucciDirector | 11,000 | — | — | 11,000 | — | |
| Jun 8, 2017 AForm 4/A → | Sep 22, 5:19 pm EDT | Srinivas AkkarajuDirector | 22,000 | — | — | 22,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:04 pm EDT | Srinivas AkkarajuDirector | 22,000 | — | — | 22,000 | — | amended |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:04 pm EDT | Marsha FanucciDirector | 11,000 | — | — | 11,000 | — | amended |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:03 pm EDT | Amir NashatDirector | 11,000 | — | — | 11,000 | — | amended |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:03 pm EDT | Sanj K PatelDirector | 11,000 | — | — | 11,000 | — | amended |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:03 pm EDT | Robert NelsenDirector, 10% Owner | 11,000 | — | — | 11,000 | — | amended |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:03 pm EDT | Vicki L SatoDirector | 11,000 | — | — | 11,000 | — | amended |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:02 pm EDT | Philip A SharpDirector | 11,000 | — | — | 11,000 | — | amended |
| Jun 8, 2017 AForm 4 → | Jun 12, 4:02 pm EDT | Richard A YoungDirector | 11,000 | — | — | 11,000 | — | amended |
| Feb 10, 2017 AForm 4 → | Feb 13, 5:17 pm EST | Kyle D. KuvalankaChief Operating Officer | 78,000 | — | — | 78,000 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 5:17 pm EST | Nancy A SimonianPresident & CEO, Director | 175,000 | — | — | 175,000 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 5:16 pm EST | Eric R OlsonChief Scientific Officer | 63,500 | — | — | 63,500 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 5:16 pm EST | Gerald E QuirkChief Legal Officer | 40,000 | — | — | 40,000 | — | |
| Feb 10, 2017 AForm 4 → | Feb 13, 5:16 pm EST | David RothChief Medical Officer | 63,500 | — | — | 63,500 | — | |
| Jan 27, 2017 AForm 4 → | Jan 30, 8:42 am EST | Peter WirthDirector | 22,000 | — | — | 22,000 | — | |
| Sep 27, 2016 AForm 4 → | Sep 29, 5:11 pm EDT | Gerald E QuirkChief Legal Officer | 105,000 | — | — | 105,000 | — | |
| Sep 16, 2016 AForm 4 → | Sep 19, 6:59 am EDT | Nancy A SimonianPresident & CEO, Director | 75,000 | — | — | 75,000 | — | |
| Sep 15, 2016 AForm 4 → | Sep 19, 6:57 am EDT | Vicki L SatoDirector | 22,000 | — | — | 22,000 | — | |
| Sep 15, 2016 AForm 4 → | Sep 19, 6:57 am EDT | Sanj K PatelDirector | 22,000 | — | — | 22,000 | — | |
| Sep 15, 2016 AForm 4 → | Sep 19, 6:56 am EDT | Philip A SharpDirector | 22,000 | — | — | 22,000 | — | |
| Sep 15, 2016 AForm 4 → | Sep 19, 6:56 am EDT | Amir NashatDirector, 10% Owner | 22,000 | — | — | 22,000 | — | |
| Sep 15, 2016 AForm 4 → | Sep 19, 6:55 am EDT | Stephane BancelDirector | 22,000 | — | — | 22,000 | — | |
| Sep 15, 2016 AForm 4 → | Sep 19, 6:55 am EDT | Richard A YoungDirector | 22,000 | — | — | 22,000 | — | |
| Sep 15, 2016 AForm 4 → | Sep 19, 6:54 am EDT | Marsha FanucciDirector | 22,000 | — | — | 22,000 | — | |
| Sep 15, 2016 AForm 4 → | Sep 19, 6:54 am EDT | Robert NelsenDirector, 10% Owner | 22,000 | — | — | 22,000 | — | |
| Jul 6, 2016 CForm 4 → | Jul 7, 5:41 pm EDT | Amir NashatDirector, 10% Owner | 4,449,954 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 7, 5:41 pm EDT | Polaris Management Co. VII, L.L.C. +210% Owner | 4,449,954 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 7, 8:15 am EDT | WuXi PharmTech Healthcare Fund I L.P.10% Owner | 3,494,471 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 7, 6:04 am EDT | Flagship Ventures Fund IV, L.P. +510% Owner | 15,724,976 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 7, 6:03 am EDT | Redmile Group, LLC +110% Owner | 1,748,196 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 7, 6:02 am EDT | Arch Venture Fund VII LP +410% Owner | 15,089,269 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:25 pm EDT | WuXi Healthcare Ventures II, L.P.10% Owner | 1,589,269 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:24 pm EDT | Stephane BancelDirector | 100,000 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:23 pm EDT | Philip A SharpDirector | 1,000,000 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:23 pm EDT | Nancy A SimonianPresident and CEO, Director | 250,000 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 6, 9:22 pm EDT | Robert NelsenDirector, 10% Owner | 15,089,269 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 6, 5:10 pm EDT | AISLING CAPITAL III LP +510% Owner | 1,907,122 | — | — | 0 | — | |
| Jul 6, 2016 CForm 4 → | Jul 6, 11:54 am EDT | James E Flynn +510% Owner | 1,695,220 | — | — | 0 | — |